Sunitinib
What is Sunitinib Sunitinib is an oral, multitargeted tyrosine kinase inhibitor with anti-angiogenic and anti-tumor activities due to selective inhibition of several receptor tyrosine kinases. Activation of gene pathways by hypoxia, such as vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), are common in solid tumors. These genes are implicated in tumor angiogenesis …